Expression and Asthma Phenotypes Associates with Its eotaxin 1 Promoter of A Single Nucleotide Polymorphism

[1]  Choon-Sik Park,et al.  Eotaxin and monocyte chemotactic protein-3 use different modes of action. , 2004, Biochemical and biophysical research communications.

[2]  K. Lamberth,et al.  CCR3 Expression Induced by IL-2 and IL-4 Functioning as a Death Receptor for B Cells1 , 2003, The Journal of Immunology.

[3]  Choon-Sik Park,et al.  Association of Interleukin-5 and Eotaxin with Acute Exacerbation of Asthma , 2003, International Archives of Allergy and Immunology.

[4]  H. Shin,et al.  Association of Eotaxin gene family with asthma and serum total IgE. , 2003, Human molecular genetics.

[5]  M. Kawaguchi,et al.  Differential regulation of eotaxin expression by IFN-γ in airway epithelial cells ☆ ☆☆ , 2003 .

[6]  Koichiro Nakamura,et al.  Eotaxin gene single nucleotide polymorphisms in the promoter and exon regions are not associated with susceptibility to atopic dermatitis, but two of them in the promoter region are associated with serum IgE levels in patients with atopic dermatitis. , 2002, Journal of dermatological science.

[7]  E. Israel,et al.  Variant eotaxin: its effects on the asthma phenotype. , 2001, The Journal of allergy and clinical immunology.

[8]  K. Chung,et al.  Evidence for systemic rather than pulmonary effects of interleukin-5 administration in asthma , 2001, Thorax.

[9]  K. Ohta,et al.  Variations in the human CC chemokine eotaxin gene , 2001, Genes and Immunity.

[10]  P. Donnelly,et al.  A new statistical method for haplotype reconstruction from population data. , 2001, American journal of human genetics.

[11]  M. Woisetschläger,et al.  STAT6 Mediates Eotaxin-1 Expression in IL-4 or TNF-α-Induced Fibroblasts , 2001, The Journal of Immunology.

[12]  F. Annunziato,et al.  Expression of the Chemokine Receptor CCR3 on Human Mast Cells , 2001, International Archives of Allergy and Immunology.

[13]  J. Bousquet,et al.  Genome screen for asthma and related phenotypes in the French EGEA study. , 2000, American journal of respiratory and critical care medicine.

[14]  E. Silverman,et al.  Case-control association studies for the genetics of complex respiratory diseases. , 2000, American journal of respiratory cell and molecular biology.

[15]  B. Nardelli,et al.  C-C Chemokine Receptor 3 Antagonism by the β-Chemokine Macrophage Inflammatory Protein 4, a Property Strongly Enhanced by an Amino-Terminal Alanine-Methionine Swap1 , 2000, The Journal of Immunology.

[16]  V. Casolaro,et al.  Activation of Eotaxin Gene Transcription by NF-κB and STAT6 in Human Airway Epithelial Cells , 1999, The Journal of Immunology.

[17]  E. Israel,et al.  Eotaxin and impaired lung function in asthma. , 1999, American journal of respiratory and critical care medicine.

[18]  K. Jarnagin,et al.  Identification of residues in the monocyte chemotactic protein-1 that contact the MCP-1 receptor, CCR2. , 1999, Biochemistry.

[19]  Choon-Sik Park,et al.  Interleukin (IL)-5 downregulates tumor necrosis factor (TNF)-induced eotaxin messenger RNA (mRNA) expression in eosinophils. Induction of eotaxin mRNA by TNF and IL-5 in eosinophils. , 1999, American journal of respiratory cell and molecular biology.

[20]  H. Ochi,et al.  T Helper Cell Type 2 Cytokine–Mediated Comitogenic Responses and Ccr3 Expression during Differentiation of Human Mast Cells in Vitro , 1999, The Journal of experimental medicine.

[21]  M. Jordana,et al.  Circulating, but not local lung, IL-5 is required for the development of antigen-induced airways eosinophilia. , 1998, The Journal of clinical investigation.

[22]  P. Murphy,et al.  The N-terminal Extracellular Segments of the Chemokine Receptors CCR1 and CCR3 Are Determinants for MIP-1α and Eotaxin Binding, Respectively, but a Second Domain Is Essential for Efficient Receptor Activation* , 1998, The Journal of Biological Chemistry.

[23]  C. Mackay,et al.  Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co‐localization of eotaxin mRNA to bronchial epithelial and endothelial cells , 1997, European journal of immunology.

[24]  C. Mackay,et al.  Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils , 1997, Current Biology.

[25]  C. Mackay,et al.  Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. , 1997, Science.

[26]  C. Mackay,et al.  High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. , 1997, The Journal of clinical investigation.

[27]  C. Schlüter,et al.  Genomic organization, sequence, and transcriptional regulation of the human eotaxin gene. , 1997, Biochemical and biophysical research communications.

[28]  M. Stacey,et al.  Eotaxin expression and eosinophilic inflammation in asthma. , 1997, Biochemical and biophysical research communications.

[29]  S. Weremowicz,et al.  Genomic organization, complete sequence, and chromosomal location of the gene for human eotaxin (SCYA11), an eosinophil-specific CC chemokine. , 1997, Genomics.

[30]  P. Foster,et al.  Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. , 1997, The Journal of clinical investigation.

[31]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[32]  C. Schlüter,et al.  Human dermal fibroblasts express eotaxin: molecular cloning, mRNA expression, and identification of eotaxin sequence variants. , 1996, Biochemical and biophysical research communications.

[33]  C. Mackay,et al.  Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils , 1996, The Journal of experimental medicine.

[34]  C. Combadière,et al.  Molecular Cloning of Human Eotaxin, an Eosinophil-selective CC Chemokine, and Identification of a Specific Eosinophil Eotaxin Receptor, CC Chemokine Receptor 3 (*) , 1996, The Journal of Biological Chemistry.

[35]  J. Fikes,et al.  Maturation of Escherichia coli maltose-binding protein by signal peptidase I in vivo. Sequence requirements for efficient processing and demonstration of an alternate cleavage site. , 1990, The Journal of biological chemistry.

[36]  S. Spector,et al.  Standardization of bronchial inhalation challenge procedures. , 1975, The Journal of allergy and clinical immunology.

[37]  E. B. Pedersen,et al.  Identification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus. , 1996, American journal of human genetics.